Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Total 13F shares
-
15,203,165
-
Share change
-
+1,392,010
-
Total reported value
-
$533,480,616
-
Put/Call ratio
-
56%
-
Price per share
-
$35.09
-
Number of holders
-
66
-
Value change
-
+$51,097,629
-
Number of buys
-
48
-
Number of sells
-
17
Institutional Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2015
As of 31 Dec 2015,
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) was held by
66 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,203,165 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, FEDERATED INVESTORS INC /PA/, BlackRock Fund Advisors, Flagship Ventures 2007 General Partner LLC, WADDELL & REED FINANCIAL INC, VANGUARD GROUP INC, TimesSquare Capital Management, LLC, JENNISON ASSOCIATES LLC, and BRIDGER MANAGEMENT, LLC.
This page lists
66
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.